Innate Pharma
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Manufacturing
Description
Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2009-02-12 17:45 |
Innate Pharma annonce l’atteinte d’un paiement d’étape pré-clinique pour un nou…
|
French | 45.7 KB | ||
| 2009-02-12 17:45 |
Innate Pharma announces the achievement of a milestone payment in a new monoclo…
|
English | 41.4 KB | ||
| 2009-02-06 17:30 |
Innate Pharma SA, société biopharmaceutique qui développe des candidat-médicame…
|
French | 34.4 KB | ||
| 2009-02-06 17:30 |
Innate Pharma SA, a biopharmaceutical company developing first-in-class drug ca…
|
English | 33.1 KB | ||
| 2009-01-21 17:40 |
Vivalis et Innate Pharma annoncent aujourd’hui la signature d’un accord de coll…
|
French | 42.9 KB | ||
| 2009-01-21 17:40 |
Vivalis and Innate Pharma sign a collaboration and commercial license agreement…
|
English | 42.0 KB | ||
| 2008-12-23 17:30 |
Innate Pharma (Euronext Paris : FR0010331421 – IPH), société biopharmaceutique …
|
French | 30.3 KB | ||
| 2008-12-23 17:30 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH), a biopharmaceutical company…
|
English | 30.0 KB | ||
| 2008-12-01 18:05 |
Innate Pharma SA annonce l’entrée en validation pré-clinique d’un nouveau candi…
|
French | 41.4 KB | ||
| 2008-12-01 18:05 |
Innate Pharma , announces today the entry in pre-clinical validation of a new d…
|
English | 40.8 KB | ||
| 2008-11-06 17:30 |
Innate Pharma SA, société biopharmaceutique qui développe des médicaments cibla…
|
French | 44.5 KB | ||
| 2008-11-06 17:30 |
Innate Pharma SA, a biopharmaceutical company developing first-in-class drugs t…
|
English | 33.9 KB | ||
| 2008-11-04 17:45 |
Innate Pharma SA annonce que le rationnel pré-clinique de l’immunothérapie cibl…
|
French | 45.2 KB | ||
| 2008-11-04 17:45 |
Innate Pharma S.A. announces today that the preclinical rationale of the gamma-…
|
English | 42.9 KB | ||
| 2008-10-20 21:01 |
Innate Pharma SA, société biopharmaceutique qui développe des médicaments cibla…
|
French | 29.9 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
Peer Companies
